Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aimmune, Alkermes, Arrowhead, Celsion, Edesa, Enanta, Evelo, Gilead, Gracell, Innovent, Kahr, Marker, Maze, Modra, Pharmazz, Poseida, Regencell, Resverlogix, Veru, XNK.